Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|9|1683-1693

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.9, 2015-09, pp. : 1683-1693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification and characterization of murine alternatively spliced tissue factor

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 158-167

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of Estrogen Receptor Beta and Phosphorylation of Estrogen Receptor Alpha Serine 167 Correlate with Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Aromatase Inhibitors

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 55-61

Karger

Access to resources Recommend Favorite

Crosstalk of TGF-β and Estrogen Receptor Signaling in Breast Cancer

By Band Arja  

Journal of Mammary Gland Biology and Neoplasia, Vol. 16, Iss. 2, 2011-06 ,pp. : 109-115

Springer Publishing Company

Access to resources Recommend Favorite

New insights into estrogen receptor function in human breast cancer

By Murphy Leigh   Cherlet Tracy   Lewis Anthony   Banu Yasmin   Watson Peter  

Annals of Medicine, Vol. 35, Iss. 8, 2003-12 ,pp. : 614-631

Informa Healthcare

Access to resources Recommend Favorite

High-Risk Estrogen-Receptor-Positive Breast Cancer: Identification and Implications for Therapy

By Balleine Rosemary L.   Wilcken Nicholas R.  

Molecular Diagnosis & Therapy, Vol. 16, Iss. 4, 2012-08 ,pp. : 235-240

Adis International

Access to resources Recommend Favorite